NuVim Inc
OTC:NUVM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NuVim Inc
OTC:NUVM
|
US |
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
|
Adacel Technologies Ltd
ASX:ADA
|
AU |
|
Takara & Company Ltd
TSE:7921
|
JP |
|
D
|
Delta Property Fund Ltd
JSE:DLT
|
ZA |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
Lincoln Gold Mining Inc
XTSX:LMG
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NUVM's stock price target?
Not Available
NUVM does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for NuVim Inc?
Projected CAGR
96%
Over the last 7 years, the compound annual growth rate for Revenue has been -35%. The projected CAGR for the next 4 years is 96%.